Published in Arch Dermatol on January 01, 1987
The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. J Am Acad Dermatol (2012) 1.79
The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi. Arch Dermatol Res (1990) 0.77
Evidence for autosomal dominance and pleiotropy of the cutaneous malignant melanoma (CMM)/Dysplastic nevus (DN) gene. Am J Hum Genet (1987) 0.75
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol (1996) 9.68
Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol (1999) 5.95
High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol (2001) 4.84
High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol (2000) 4.60
The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med (1994) 3.20
Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. J Infect Dis (1988) 3.02
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol (2000) 2.37
Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum (1988) 2.21
Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depth. Br J Dermatol (2012) 2.20
The histopathology of experimentally infected hamsters with the Lyme disease spirochete, Borrelia burgdorferi. Proc Soc Exp Biol Med (1986) 2.18
Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons. Lancet (1997) 2.09
Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol (1996) 2.06
Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium. Ann Intern Med (1985) 2.04
Lyme arthritis. Spirochetes found in synovial microangiopathic lesions. Am J Pathol (1985) 2.03
Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res (1995) 1.85
Prevalence of Borrelia burgdorferi in white-footed mice and Ixodes dammini at Fort McCoy, Wis. J Clin Microbiol (1987) 1.82
Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res (1996) 1.78
Experimental infection of the hamster with Borrelia burgdorferi. Ann N Y Acad Sci (1988) 1.77
Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci U S A (1992) 1.58
Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene (2006) 1.53
Correlation of histologic architectural and cytoplasmic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi. Hum Pathol (1990) 1.51
High-dose cisplatin and dacarbazine in the treatment of metastatic melanoma. J Natl Cancer Inst (1990) 1.51
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res (2000) 1.50
Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study. Hum Pathol (1989) 1.48
A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods (1999) 1.46
Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer. J Urol (1999) 1.41
Infantile myofibromatosis. Evidence for an autosomal-dominant disorder. Am J Surg Pathol (1984) 1.32
In vivo description of dendritic cells in human renal cell carcinoma. J Urol (1999) 1.23
Construction of a representative cDNA library from prostatic intraepithelial neoplasia. Cancer Res (1996) 1.23
Interferons in the treatment of human cancer. J Clin Oncol (1984) 1.22
The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey. Vaccine (1997) 1.21
Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis (2000) 1.18
Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. J Immunother Emphasis Tumor Immunol (1996) 1.16
Adenocarcinoid (mucinous carcinoid) of the appendix. Gastroenterology (1984) 1.15
Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med (1985) 1.13
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet (2003) 1.13
Langerhans cell histiocytosis of the female genital tract. Cancer (1991) 1.13
Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma. Cytotherapy (2006) 1.11
Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res (1997) 1.10
The surgical pathology of human Lyme disease. An enlarging picture. Am J Surg Pathol (1987) 1.10
Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens. Urology (1997) 1.08
Borrelial fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection. Am J Dermatopathol (1996) 1.07
Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay. Biochem Biophys Res Commun (2000) 1.06
Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Res (1996) 1.06
Borrelia burgdorferi myositis: report of eight patients. J Neurol (1993) 1.05
Hepatobiliary lymphoepithelioma-like carcinoma associated with Epstein-Barr virus. Am J Clin Pathol (1998) 1.05
Borrelia burgdorferi and Ixodes dammini prevalent in the greater Philadelphia area. J Infect Dis (1990) 1.03
Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium. J Urol (2001) 1.02
Unusual form of recurrent giant cell granuloma of the mandible and lower extremities in a patient with neurofibromatosis type 1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1999) 1.02
Myositis caused by Borrelia burgdorferi: report of four cases. J Neurol Sci (1989) 1.01
Molecular profiling of clinical tissue specimens: feasibility and applications. Am J Pathol (2000) 1.00
Complete heart block in a dog seropositive for Borrelia burgdorferi. Similarity to human Lyme carditis. J Vet Intern Med (1989) 1.00
Molecular profiling of clinical tissues specimens: feasibility and applications. J Mol Diagn (2000) 0.98
Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers. Ann Intern Med (1985) 0.98
Immunohistochemical expression of pi-class glutathione S-transferase is down-regulated in adenocarcinoma of the prostate. Cancer (1997) 0.97
Microcystic adnexal carcinoma associated with primary immunodeficiency, recurrent diffuse herpes simplex virus infection, and cutaneous T-cell lymphoma. Am J Dermatopathol (2000) 0.97
Identification of a novel transcript up-regulated in a clinically aggressive prostate carcinoma. Urology (1997) 0.97
Lyme myositis: muscle invasion by Borrelia burgdorferi. Ann Intern Med (1988) 0.96
Warty dyskeratoma of the vulva. Int J Gynecol Pathol (1983) 0.95
Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I. J Immunol Methods (2001) 0.94
A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial. Cancer Res (1985) 0.94
Maximum androgen-blockade with medical or surgical castration in advanced prostate cancer: A meta-analysis of nine published randomized controlled trials and 4128 patients using flutamide. Prostate Cancer Prostatic Dis (1999) 0.94
Cystitis induced by infection with the Lyme disease spirochete, Borrelia burgdorferi, in mice. Am J Pathol (1992) 0.94
An analysis of interobserver recognition of the histopathologic features of dysplastic nevi from a mixed group of nevomelanocytic lesions. J Am Acad Dermatol (1992) 0.93
Phase I/II study of murine monoclonal antibody-ricin A chain (XOMAZYME-Mel) immunoconjugate plus cyclosporine A in patients with metastatic melanoma. J Immunother Emphasis Tumor Immunol (1993) 0.93
Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder. J Urol (1991) 0.92
Pigmented renal clear cell carcinoma with melanocytic differentiation. Hum Pathol (2001) 0.91
Small intestinal angiodysplasia in the elderly. J Clin Gastroenterol (1984) 0.91
The NIH-3 immunodeficient mouse is a model for Lyme borreliosis myositis and carditis. Am J Pathol (1992) 0.91
Long term organ culture of human prostate tissue in a NASA-designed rotating wall bioreactor. J Urol (1999) 0.90
The histological spectrum of hemangiopericytoma: application of immunohistochemical analysis including proliferative markers to facilitate diagnosis and predict prognosis. Hum Pathol (1998) 0.90
Expression of Fas(APO-1/CD95) in tumor-infiltrating and peripheral blood lymphocytes in patients with renal cell carcinoma. Cancer Res (1998) 0.89
Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up. Melanoma Res (1995) 0.88
The spectrum of organ and systems pathology in human Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.88
Unilateral blindness caused by infection with the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med (1985) 0.87
Polypoid dysplasia in Barrett's esophagus: a clinicopathologic, immunohistochemical, and molecular study of five cases. Hum Pathol (1999) 0.87
Scintigraphic detection of metastatic melanoma using indium 111/DTPA conjugated anti-gp240 antibody (ZME-018). J Clin Oncol (1987) 0.87
Gastrointestinal angiodysplasia: a possible component of von Willebrand's disease. Hum Pathol (1984) 0.87
Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladder. Cancer (1990) 0.86
Giant retroperitoneal neurilemoma: a rare cause of digestive tract symptoms. J Clin Gastroenterol (1983) 0.86
Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter. Am J Pathol (2001) 0.86
Sonographic characteristics of epidermoid cyst of testicle. Urology (1990) 0.85
Diagnostic tests in Lyme borreliosis. Scand J Infect Dis Suppl (1991) 0.85
Morphology of Borrelia burgdorferi: structural patterns of cultured borreliae in relation to staining methods. J Clin Microbiol (1991) 0.84
Approaches to preclinical screening of antiangiogenic agents. Semin Oncol (2001) 0.84
Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr Infect Dis J (1988) 0.84
The rapid onset of cutaneous angiosarcoma after radiotherapy for breast carcinoma. Cancer (1986) 0.83
Dysplastic nevi in association with multiple primary melanoma. Cancer Res (1988) 0.83
Role of interferons in the therapy of melanoma. J Invest Dermatol (1990) 0.83
Ultrastructural demonstration of spirochetal antigens in synovial fluid and synovial membrane in chronic Lyme disease: possible factors contributing to persistence of organisms. Hum Pathol (1996) 0.83
Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myeloma. Bone Marrow Transplant (2007) 0.83
T-cell receptor zeta-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma. Cancer Res (1997) 0.82
Inter-clinician agreement on the recognition of clinical pigmentary characteristics of patients with cutaneous malignant melanoma. Studies of melanocytic nevi, VI. Br J Cancer (1991) 0.82
Hepatitis due to recurrent Lyme disease. Ann Intern Med (1988) 0.82
DNA analysis of multiple synchronous renal cell carcinomas. Cancer (1990) 0.81
A relation between childhood sun exposure and dysplastic nevus syndrome among patients with nonfamilial melanoma. Epidemiology (1991) 0.81
Preparation of viable tumour cell vaccine from human solid tumours: relationship between tumour mass and cell yield. The Tissue Bank, Pittsburgh Cancer Institute. Melanoma Res (1993) 0.81